Nancy A. Yuen

Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™

Ayako Suzuki, Raúl J. Andrade, Einar S. Björnsson et al. · Drug Safety · 2010 · 168 citations · Full text

Drug Interactions, Hepatic Disorders, Hepatology +10

Comparative Performance of Two Quantitative Safety Signalling Methods

June S. Almenoff, Karol LaCroix, Nancy A. Yuen et al. · Drug Safety · 2006 · 108 citations

Reliability, Engineering, Safety Science +6

Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™

Ayako Suzuki, Nancy A. Yuen, Katarina Ilić et al. · Regulatory Toxicology and Pharmacology · 2015 · 61 citations · Full text

Drug Interactions, Hepatology, Data Mining +7

Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database

Christine M. Hunt, Nancy A. Yuen, Heide A. Stirnadel-Farrant et al. · Regulatory Toxicology and Pharmacology · 2014 · 59 citations · Full text

Drug Safety, Hepatology, Liver Physiology +11

A pre-marketing ALT signal predicts post-marketing liver safety

Cynthia A. Moylan, Ayako Suzuki, Julie I. Papay et al. · Regulatory Toxicology and Pharmacology · 2012 · 15 citations

Advertising, Hepatology, Liver Physiology +7